Search research articles
Contact Us
Filters
Showing results (61-70 of 261) with videos related to
Page
of 27
Sort By:
The EMBO Journal
|
December 15, 1993
Targeted disruption of the M(r) 46,000 mannose 6-phosphate receptor gene in mice results in misrouting of lysosomal proteins
A Köster, P Saftig, U Matzner, et al.
Journal of Microencapsulation
|
April 25, 2007
Microparticles prepared with poly(hydroxybutyrate-co-hydroxyvalerate) and poly(epsilon-caprolactone) blends to control the release of a drug model
Maria I Z Lionzo, Maria I Ré, Silvia S Guterres, et al.
Journal of Nanoscience and Nanotechnology
|
April 1, 2011
Simultaneous control of capsaicinoids release from polymeric nanocapsules
Renata V Contri, Moacir Kaiser, Fernanda S Poletto, et al.
Journal of Nanoscience and Nanotechnology
|
July 20, 2016
Development of an Insect Repellent Spray for Textile Based on Permethrin-Loaded Lipid-Core Nanocapsules
Joana C Forgearini, Cecília B Michalowski, Evelise Assumpção, et al.
International Journal of Pharmaceutics
|
May 8, 2007
Human skin penetration and distribution of nimesulide from hydrophilic gels containing nanocarriers
Marta P Alves, Ana L Scarrone, Marcos Santos, et al.
International Journal of Pharmaceutics
|
July 3, 2007
Rate-modulating PHBHV/PCL microparticles containing weak acid model drugs
Fernanda S Poletto, Eliézer Jäger, Maria I Ré, et al.
International Journal of Nanomedicine
|
March 11, 2014
The use of nanoencapsulation to decrease human skin irritation caused by capsaicinoids
Renata V Contri, Luiza A Frank, Moacir Kaiser, et al.
Revista Gaucha De Odontologia
|
April 1, 1973
[Hypoplasias. How and why to treat clinically]
A R Pohlmann, H P de Bellagamba, C A Lorenzo, et al.
Drug Delivery and Translational Research
|
June 21, 2020
New pectin-based hydrogel containing imiquimod-loaded polymeric nanocapsules for melanoma treatment
R P Gazzi, L A Frank, G Onzi, et al.
Contemporary Clinical Trials Communications
|
April 7, 2023
A phase I trial of palbociclib and bosutinib with fulvestrant in patients with metastatic hormone receptor positive and HER2 negative (HR+ HER2-) breast cancer refractory to an aromatase inhibitor and a CDK4/6 inhibitor
Tina Roy, Elizabeth Barrows, Candace Mainor, et al.
Page
of 27
Search research articles
Search
Showing results (61-70 of 261) with videos related to
Sort By:
Page
of 27
The EMBO Journal
|
December 15, 1993
Targeted disruption of the M(r) 46,000 mannose 6-phosphate receptor gene in mice results in misrouting of lysosomal proteins
A Köster, P Saftig, U Matzner, et al.
Journal of Microencapsulation
|
April 25, 2007
Microparticles prepared with poly(hydroxybutyrate-co-hydroxyvalerate) and poly(epsilon-caprolactone) blends to control the release of a drug model
Maria I Z Lionzo, Maria I Ré, Silvia S Guterres, et al.
Journal of Nanoscience and Nanotechnology
|
April 1, 2011
Simultaneous control of capsaicinoids release from polymeric nanocapsules
Renata V Contri, Moacir Kaiser, Fernanda S Poletto, et al.
Journal of Nanoscience and Nanotechnology
|
July 20, 2016
Development of an Insect Repellent Spray for Textile Based on Permethrin-Loaded Lipid-Core Nanocapsules
Joana C Forgearini, Cecília B Michalowski, Evelise Assumpção, et al.
International Journal of Pharmaceutics
|
May 8, 2007
Human skin penetration and distribution of nimesulide from hydrophilic gels containing nanocarriers
Marta P Alves, Ana L Scarrone, Marcos Santos, et al.
International Journal of Pharmaceutics
|
July 3, 2007
Rate-modulating PHBHV/PCL microparticles containing weak acid model drugs
Fernanda S Poletto, Eliézer Jäger, Maria I Ré, et al.
International Journal of Nanomedicine
|
March 11, 2014
The use of nanoencapsulation to decrease human skin irritation caused by capsaicinoids
Renata V Contri, Luiza A Frank, Moacir Kaiser, et al.
Revista Gaucha De Odontologia
|
April 1, 1973
[Hypoplasias. How and why to treat clinically]
A R Pohlmann, H P de Bellagamba, C A Lorenzo, et al.
Drug Delivery and Translational Research
|
June 21, 2020
New pectin-based hydrogel containing imiquimod-loaded polymeric nanocapsules for melanoma treatment
R P Gazzi, L A Frank, G Onzi, et al.
Contemporary Clinical Trials Communications
|
April 7, 2023
A phase I trial of palbociclib and bosutinib with fulvestrant in patients with metastatic hormone receptor positive and HER2 negative (HR+ HER2-) breast cancer refractory to an aromatase inhibitor and a CDK4/6 inhibitor
Tina Roy, Elizabeth Barrows, Candace Mainor, et al.
Page
of 27